Device Trial Radar · NCT03193021
AMBULATE: Cardiva Mid-Bore VVCS vs. Manual Compression for Multiple Femoral Venous Access Sites, 6 - 12F ID
Last checked: Nov 21, 2026Latest source record: Mar 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
204
Actual
Start
Sep 20, 2017
Primary completion
Apr 13, 2018
Study completion Apr 13, 2018
Sponsor
- Lead sponsor
- Cardiva Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 20, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the trial is to demonstrate the safety and effectiveness of the Cardiva Mid-Bore Venous Vascular Closure System (VVCS) in sealing femoral venous access sites and providing reduced times to ambulation (TTA) compared with manual compression at the completion of catheter-based procedures performed through 6 - 12 Fr introducer sheaths.
Conditions
- Surgical Wound
Interventions
Cardiva Mid-Bore VVCSDevice
The device will be used to close all femoral venous access sites at the end of the case, which range from 3 - 4 access sites per patient.
Manual compressionOther
Manual compression will be used to achieve hemostasis in all femoral venous access sites when the sheaths are pulled, which range from 3-4 access sites per patient.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Ambulation (TTA)Time frame: Post-procedure, usually within 6 hours
1 more outcomes with a free account
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Alaska Heart & Vascular
Anchorage, Alaska
12 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.